(30 cm3). The product was recrystallised from diethyl ether and
1-[(R)-1-(1-Naphthyl)ethylcarbamoylmethyl]-1,4,7,10-tetra-
was isolated as white needles (1.1 g, 76%); m.p. 144–145 ЊC;
azacyclododecane (R)-5a.
νmax(KBr)/cmϪ1 3296 (N᎐H), 1648 (C᎐O); δ (250 MHz; CDCl )
᎐
H
3
H
8.12–7.48 (7 H, m, C10H7), 6.84 (1 H, br s, NH), 5.99 (1 H, m,
H
N
H
N
2
2
CH), 4.13 (1 H, d, J 15.3, CH2), 4.11 (1 H, d, J 15.3, CH2),
1.75 (3 H, d, 3J 7.0 Hz, CH3); δC{1H} (62.9 MHz; CDCl3) 165.0
(CO), 137.5 (C10H7), 133.9 (C10H7), 130.9 (C10H7), 128.9
(C10H7), 128.6 (C10H7), 126.8 (C10H7), 126.0 (C10H7), 125.3
(C10H7), 123.1 (C10H7), 122.6 (C10H7), 45.2 (CH), 42.6 (CH2),
20.9 (CH3); m/z (DCI) 248 (100%, MHϩ), 212 (18%, Mϩ Ϫ Cl),
155 (70%, Mϩ Ϫ NHCOCl) (Found: C, 68.1; H, 5.64; N, 5.59.
C14H14ClON requires C, 67.8; H, 5.69; N, 5.65%).
N
N
H7C10 Me
O
N
H
H
This compound was prepared following a similar method to
that for compound 6a using 1,4,7,10-tetraazacyclododecane–
molybdenum–tricarbonyl complex (1 g, 2.86 mmol), 2-chloro-
N-[(R)-1-naphthyl]ethylethanamide 3a (0.71 g, 2.86 mmol) and
potassium carbonate (0.55 g, 4.0 mmol) in degassed, dry
dimethylformamide (30 cm3) to yield a brown oil (0.55 g, 50%)
2-Chloro-N-[(S)-1-naphthyl]ethylethanamide (S)-3b.
O
H7C10 Me
after purification; νmax(film)/cmϪ1 3421 (N᎐H), 1643 (C᎐O);
᎐
3
Cl
δH(250 MHz; CDCl3) 8.52 (1 H, d, J 8.0, NHCO), 8.12–7.49
(7 H, m, C10H7), 5.95 (1 H, m, CH), 3.25 (1 H, d, J 17.5,
CH2CO), 3.19 (1 H, d, J 17.5, CH2CO), 2.59–2.20 (19 H, m,
H
N
2
H
2
ring-CH2, ring-NH), 1.71 (3 H, d, 3J 6.9 Hz, CH3); δC{1H} (62.9
MHz; CDCl3), 170.6 (CO), 138.2 (q-C10H7), 133.6 (q-C10H7),
131.2 (q-C10H7), 128.6 (C10H7), 128.0 (C10H7), 126.4 (C10H7),
125.8 (C10H7), 125.2 (C10H7), 123.5 (C10H7), 122.9 (C10H7), 58.9
(CH2CO), 53.4 (ring-CH2), 46.8 (ring-CH2), 45.6 (ring-CH2),
44.5 (ring-CH2), 43.9 (CHN), 20.0 (CH3); m/z (DCI) 384
(100%, MHϩ).
This compound was prepared following a method similar to
that for compound 2 using (S)-1-(1-naphthyl)ethylamine (4.72
cm3, 29.2 mmol) and triethylamine (4.9 cm3, 35.1 mmol) in dry
diethyl ether (100 cm3) and treating with a solution of chloro-
acetyl chloride (2.79 cm3, 35.1 mmol) in dry diethyl ether (50
cm3). The product was recrystallised from diethyl ether and was
isolated as white needles (3.5 g, 48%). Characterisation data are
the same as those reported for 3a (Found: C, 68.0; H, 5.60; N,
5.54. C14H14ClON requires C, 67.8; H, 5.69; N, 5.65%).
1-[(S)-1-(1-Naphthyl)ethylcarbamoylmethyl]-1,4,7,10-tetra-
azacyclododecane (S)-5b.
1-[(S)-1-(1-Phenyl)ethylcarbamoylmethyl]-1,4,7,10-tetraaza-
cyclododecane (S)-6a.
H
H
N
H
N
N
N
N
H
H
N
Me
C10H7
O
H
N
N
N
N
Ph
Me
H
H
O
This compound was prepared following a similar method to
that for compound 6a using 1,4,7,10-tetraazacyclododecane–
molybdenum–tricarbonyl complex (4.2 g, 12.1 mmol), 2-chloro-
N-[(S)-1-naphthyl]ethylethanamide 3b (3.0 g, 12.1 mmol) and
potassium carbonate (2.34 g, 17 mmol) in degassed, dry
dimethylformamide (60 cm3) to yield a brown oil (2.3 g, 50%)
after purification. Characterisation data are the same as those
reported for (R)-5a.
H
H
1,4,7,10-Tetraazacyclododecane (0.4 g, 2.3 mmol) and molyb-
denum hexacarbonyl (0.6 g, 2.3 mmol) in dry dibutyl ether (20
cm3) were heated at reflux under argon for 2 h to give a bright
yellow precipitate of the 1,4,7,10-tetraazacyclododecane–
molybdenum–tricarbonyl complex (16) which was filtered
under argon and dried in vacuo. The complex (16) (0.8 g, 2.3
mmol) and fine mesh anhyhdrous potassium carbonate (0.4 g,
2.8 mmol) were taken into degassed dimethylformamide (30
cm3) and a solution of 2-chloro-N-[(S)-methylbenzyl]ethan-
amide 2 (0.45 g, 2.3 mmol) in dry dimethylformamide (1 cm3)
was added under argon by steel cannula. The reaction mixture
was heated at 60 ЊC for 4 h under an argon atmosphere. The
solvent was removed by distillation in vacuo and the brown
residue was taken into hydrochloric acid (1 mol dmϪ3, 13 cm3)
and the resulting acidic brown suspension was stirred open to
the air for 18 h. Molybdenum residues were removed by centri-
fugation and filtration and the aqueous layer was washed with
dichloromethane (30 cm3) and chloroform (20 cm3). The pH of
the solution was raised to 14 by addition of sodium hydroxide
pellets, with cooling. The product was extracted into dichloro-
methane (3 × 30 cm3), washed with water (3 × 30 cm3), dried
(K2CO3) and the solvent removed in vacuo to yield a yellow-
brown oil (620 mg, 81%); Rf (Al2O3; 10% CH3OH–CH2Cl2; I2
1-[(1-Naphthyl)methylcarbamoylmethyl]-1,4,7,10-tetraaza-
cyclododecane 5c.
H
C10H7
N
H
N
N
N
N
O
H
H
This compound was prepared following a method similar to
that for compound 6a using 1,4,7,10-tetraazacyclododecane–
molybdenum–tricarbonyl complex (0.75 g, 2.14 mmol), 2-
chloro-N-(naphthylmethyl)ethanamide5 (0.5 g, 2.14 mmol) and
potassium carbonate (0.35 g, 2.57 mmol) in degassed, dry
dimethylformamide (30 cm3) to yield a yellow oil (0.2 g, 25%)
after purification; νmax(film)/cmϪ1 3365 (N᎐H), 1652 (C᎐O);
᎐
and UV detection) 0.44–0.1; νmax(film)cmϪ1 3285 (N᎐H), 1666
δH(250 MHz; CDCl3) 8.50–8.40 (1 H, br m, NHCO), 7.82–7.76
(4 H, m, C10H7), 7.48–7.41 (3 H, m, C10H7), 4.61 (2 H, d, 3J 5.0,
CH2C10H7), 3.24 (2 H, s, CH2CO), 2.69–2.39 (19 H, m, ring-
CH2, ring-NH); δC{1H} (62.9 MHz; CDCl3) 171.3 (CO), 135.9
(C10H7), 133.0 (C10H7), 132.3 (C10H7), 128.1 (C10H7), 127.5
(C10H7), 127.4 (C10H7), 126.4 (C10H7), 126.2 (C10H7), 126.1
(C10H7), 125.7 (C10H7), 59.1 (CH2CO), 53.1 (ring-CH2), 46.9
(ring-CH2), 46.3 (ring-CH2), 45.6 (ring-CH2), 43.1 (CH2C10H7);
m/z (DCI) 370 (100%, MHϩ).
3
(C᎐O); δ (250 MHz; CDCl ) 8.23 (1 H, d, J 7.7, NHCO),
᎐
H
3
7.45–7.28 (5 H, m, C6H5), 5.21 (1 H, m, CH), 3.20 (2 H, s, CH2),
2.92–2.54 (16 H, m, ring-CH2), 2.00–1.90 (3 H, m, ring-NH),
1.56 (3 H, d, 3J 5.0 Hz, CH3); δC{1H} (62.9 MHz; CDCl3) 170.3
(CO), 143.3 (q-C6H5), 128.2 (m-C6H5), 126.8 (p-C6H5), 126.1
(o-C6H5), 58.8 (CH2CO), 52.9 (ring-CH2), 48.0 (CHN), 46.7
(ring-CH2), 46.4 (ring-CH2), 45.3 (ring-CH2), 21.3 (CH3); m/z
(DCI) 334 (100%, Mϩ).
888
J. Chem. Soc., Dalton Trans., 1998, Pages 881–892